Abstract
We have recently developed the so‐called recombinant immunoporter as a non‐viral vector based on a single‐chain antibody (scFv) derived from a monoclonal antibody B4G7 against epidermal growth factor (EGF) receptor. This immunoporter (mBBD20) was composed of single‐chain antibody and negatively charged oligopeptide tail [5 units of Asn4Ser (D20)], and was expressed in yeast as a secreted protein. The purified mBBD20 was converted to an immunogene by mixing it with DNA and a cationic polymer, polyethyleneimine (PEI). The resulting complex, namely recombinant immunogene, exhibited gene transfer activity with EGFRspecificity in vitro (Suzuki et al., Gene Ther. 2003). In this paper, we further improved various conditions necessary for the formation of the proper recombinant immunogene, retaining receptor specificity of its binding, intracellular processing of the receptorbound gene, and efficient gene expression. Moreover, we provided evidence that the recombinant immunoporter made with humanized scFv could be used as a potent gene transfer vehicle to target particular tumor cells. This approach seems worthy of clinical trial.
References
- 1. Chen J, Gamou S, Takayanagi A, Shimizu N. A novel gene delivery system using EGF receptor‐mediated endocytosis. FEBS Lett 1994; 338: 167–9. [DOI] [PubMed] [Google Scholar]
- 2. Shimizu N, Chen J, Takayanagi A, Gamou S. Use of the growth factor receptor‐mediated endocytosis for therapeutic gene delivery: immunogene approach. Cell Pharmacol AIDS Sci 1996; 3: 263–7. [Google Scholar]
- 3. Shimizu N, Chen J, Gamou S, Takayanagi A. Immunogene approach toward cancer therapy using erythrocyte growth factor receptor‐mediated gene delivery. Cancer Gene Ther 1996; 3: 113–20. [PubMed] [Google Scholar]
- 4. Chen J, Gamou S, Takayanagi A, Ohtake Y, Ohtsubo M, Shimizu N. Receptor‐mediated gene delivery using the Fab fragments of anti‐epidermal growth factor receptor antibodies: improved immunogene approach. Cancer Gene Ther 1998; 5: 357–64. [PubMed] [Google Scholar]
- 5. Chen J, Gamou S, Takayanagi A, Ohtake Y, Ohtsubo M, Shimizu N. Targeted in vivo delivery of therapeutic gene into experimental squamous cell carcinomas using anti‐epidermal growth factor receptor antibody: immunogene approach. Hum Gene Ther 1998; 9: 2673–81. [DOI] [PubMed] [Google Scholar]
- 6. Ohtake Y, Chen J, Gamou S, Takayanagi A, Mashima Y, Oguchi Y, Shimizu N. Ex vivo delivery of suicide genes into melanoma cells using epidermal growth factor receptor‐specific Fab immunogene. Jpn J Cancer Res 1999; 90: 460–8. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 7. Colcher D, Pavlinkova G, Beresford G, Booth BJ, Choudhury A, Batra SK. Pharmacokinetics and biodistribution of genetically‐engineered antibodies. Q J Nucl Med 1998; 42: 225–41. [PubMed] [Google Scholar]
- 8. Ward ES. Antibody engineering using Escherichia coli as host. Adv Pharmacol 1993; 24: 1–20. [DOI] [PubMed] [Google Scholar]
- 9. Freyre FW, Vazquez JE, Ayala M, Canaan‐Haden L, Bell H, Rodriguez I, Gonzalez A, Cintado A, Gavilondo JV. Very high expression of an anti‐carcinoembryonic antigen single chain Fv antibody fragment in the yeas Pichia pastoris. J Biotechnol 2000; 76: 157–63. [DOI] [PubMed] [Google Scholar]
- 10. Li E, Pedraza A, Bestagno M, Mancardi S, Sanchez R, Burrone O. Mammalian cell expression of dimeric small immune proteins (SIP). Protein Eng 1997; 10: 731–6. [DOI] [PubMed] [Google Scholar]
- 11. Suzuki M, Takayanagi A, Shimizu N. Recombinant single‐chain antibodies with various oligopeptide tails for targeted gene delivery. Gene Ther 2003; 10: 781–8. [DOI] [PubMed] [Google Scholar]
- 12. Ogris M, Steinlein P, Kursa M, Mechtler K, Kircheis R, Wagner E. The size of DNA/transferrin‐PEI complexes is an important factor for gene expression in cultured cells. Gene Ther 1998; 5: 1425–33. [DOI] [PubMed] [Google Scholar]
- 13. Kircheis R, Wightman L, Schreiber A, Robitza B, Rossler V, Kursa M, Wagner E. Polyethylenimine/DNA complexes shielded by transferrin target gene expression to tumors after systemic application. Gene Ther 2001; 8: 28–40. [DOI] [PubMed] [Google Scholar]
- 14. Godbey WT, Wu KK, Mikos AG. Tracking the intracellular path of poly(ethylenimine)/DNA complexes for gene delivery. Proc Natl Acad Sci USA 1999; 96: 5177–81. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 15. Huston JS, Mudgett‐Hunter M, Tai MS, McCartney J, Warren F, Haber E, Oppermann H. Protein engineering of single‐chain Fv analogs and fusion proteins. Methods Enzymol 1991; 203: 46–88. [DOI] [PubMed] [Google Scholar]
- 16. Ogris M, Brunner S, Schuller S, Kircheis R, Wagner E. PEGylated DNA/transferrin‐PEI complexes: reduced interaction with blood components, extended circulation in blood and potential for systemic gene delivery. Gene Ther 1999; 6: 595–605. [DOI] [PubMed] [Google Scholar]
- 17. Ozawa S, Ueda M, Ando N, Abe O, Minoshima S, Shimizu N. Selective killing of squamous carcinoma cells by an immunotoxin that recognizes the EGF receptor. Int J Cancer 1989; 43: 152–7. [DOI] [PubMed] [Google Scholar]
- 18. Fukuyama R, Shimizu N. Detection of epidermal growth factor receptors and E‐cadherins in the basolateral membrane of A431 cells by laser scanning fluorescence microscopy. Jpn J Cancer Res 1991; 82: 8–11. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 19. Springer CJ, Niculescu‐Duvaz I. Prodrug‐activating systems in suicide gene therapy. J Clin Invest 2000; 105: 1161–7. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 20. Behzadian MA, Shimizu N. Monoclonal antibody that immunoreacts with a subclass of human receptors for epidermal growth factor. Cell Struct Funct 1985; 10: 219–32. [DOI] [PubMed] [Google Scholar]
- 21. Gamou S, Shimagaki M, Minoshima S, Kobayashi S, Shimizu N. Subcellular localization of the EGF receptor maturation process. Exp Cell Res 1989; 183: 197–206. [DOI] [PubMed] [Google Scholar]
- 22. Gamou S, Hirai M, Rikimaru K, Enomoto S, Shimizu N. Biosynthesis of the epidermal growth factor receptor in human squamous cell carcinoma lines: secretion of the truncated receptor is not common to epidermal growth factor receptor‐hyperproducing cells. Cell Struct Funct 1988; 13: 25–38. [DOI] [PubMed] [Google Scholar]
- 23. Yamamoto T, Kamata N, Kawano H, Shimizu S, Kuroki T, Toyoshima K, Rikimaru K, Nomura N, Ishizaki R, Pastan I et al. High incidence of amplifi‐cation of the epidermal growth factor receptor gene in human squamous carcinoma cell line. Cancer Res 1986; 46: 414–6. [PubMed] [Google Scholar]